The fourth state of matter, plasma: A technology to improve bone healing?
Cold plasma looks like the glow from the "Star Wars" blue light saber but this beam of energy, made of electrons that change polarity at micro-second or nanosecond speeds, could help bones heal faster, according to a study.

This image shows nanosecond cold-plasma treatment.
The laboratory of Theresa Freeman, Thomas Jefferson University.

This is a microsecond filament pattern of cold plasma at various frequencies.
The laboratory of Theresa Freeman, Thomas Jefferson University.


Most people interact with plasma every day. It's in our TVs, fluorescent lights, lightning, the aurora borealis, and the sun. However, these are all examples of hot or "thermal" plasmas. Since the discovery of cold plasma, about 20 years ago, it has been used in agriculture to sterilize the surface of fruit without damaging the delicate edibles. More recently, scientists have been performing experiments treating living animal cells and tissues with cold plasma to learn more about its potential applications in medicine.
"We've previously studied how different applications of cold plasma can either directly kill cells, such as in skin cancer, or help them grow, as in developing bones. In this study, we asked how cold plasma would affect the area surrounding cells, known as the extracellular matrix," says lead author Theresa Freeman, Ph.D., Associate Professor in the Department of Orthopedic Surgery in the Sidney Kimmel Medical College at Thomas Jefferson University . The extracellular matrix around cells is made of collagen and other proteins that interact with the cells and can influence their growth and behavior. For example, the extracellular matrix can either promote or inhibit bone formation or cancer cell growth and metastasis.
"We showed that matrix treated with cold plasma generated using microsecond pulsing can promote differentiation of cells into cartilage and increase bone formation," says Dr. Freeman. "Conversely, we showed matrix treated with nanosecond-pulsed cold plasma inhibited cell differentiation and bone formation."
The study demonstrates that cold plasma may be "tuned" to either promote or inhibit cell/matrix interactions by chemically altering the matrix.
The researchers started their experiments by exposing a commercially available extracellular matrix, (Matrigel) to either nanosecond or microsecond pulsed cold plasma at different frequencies. When microsecond cold plasma-treated Matrigel was inserted into a mouse, cells entered the gel and began the process of bone formation. However, far fewer cells entered the nanosecond plasma-treated Matrigel, and bone formation was stunted. Using an in vitro assay, Dr. Freeman and colleagues showed that cells grown on microsecond plasma-treated collagen had higher levels of focal adhesion kinase activation, indicating better cell/matrix attachments which helps initiate bone formation. There were also higher levels of anti-apoptotic proteins, suggesting better cell viability than in nanosecond-cold plasma treated collagen.
"As research into medical applications of cold plasma expands, it will be important to study various plasma types and conditions in tissue models, rather than isolated cells," says Dr. Freeman, "Because cold plasma affects each cell type and matrix protein to produce variable physiological effects," says Dr. Freeman, "it's important to study not just how each cell behaves when exposed, but how they react together within the tissue and organismal environment."
Original publication
Original publication
Eisenhauer, P., Chernets, N., Song, Y., Dobrynin, D., Pleshko, N., Steinbeck, M. J., and Freeman, T. A.; "Chemical modification of extracellular matrix by cold atmospheric plasma-generated reactive species affects chondrogenesis and bone formation"; J Tissue Eng Regen Med; 2016
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella - Project Also Seeks to Develop Better Tools to Test Truth of Seafood Labels

Improved prognosis of malaria spread
Structure of protective protein in the eye lens revealed - Heat shock proteins provide protection against cataracts

Acetate regulates immune cells for a precisely orchestrated immune defense - Similar to a pressure valve, which prevents the pressure from rising to critical levels, the regulation of immune cells by acetate prevents the immune reaction from overshooting
Congenital_absence_of_the_vas_deferens
Merck Intends to Submit Cladribine Tablets to Treat Multiple Sclerosis for Registration in Europe - Decision based on data available from the Cladribine Tablets clinical program and performed analyses
Decriminalization_of_non-medical_marijuana_in_the_United_States
Category:Pseudomonadales

Proscan elektronische Systeme GmbH - Graben, Germany

Pharmacoscopy: Next-Generation Microscopy - New possibilities for drug discovery
New triggerable, tough hydrogels could make drug-releasing systems safer
